Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings (Accumulated Deficit)	Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2021		131,161,404
Beginning balance at Dec. 31, 2021	$ 1,431,849	$ 13	$ 1,571,535	$ (1,099)	$ (138,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with a grant agreement (in shares)		881,365
Issuance of common stock in connection with a grant agreement	28,462		28,462
Vesting of restricted common stock (in shares)		323,700
Exercise of stock option (in shares)		566,714
Exercise of stock options	3,602		3,602
Issuance of common stock under employee stock purchase plan (in shares)		94,175
Issuance of common stock under employee stock purchase plan	2,066		2,066
Stock-based compensation	77,217		77,217
Other comprehensive income (loss)	(10,781)			(10,781)
Net (loss) income	617,440				617,440
Ending balance (in shares) at Sep. 30, 2022		133,027,358
Ending balance at Sep. 30, 2022	2,149,855	$ 13	1,682,882	(11,880)	478,840	$ 0
Beginning balance (in shares) at Jun. 30, 2022		132,597,812
Beginning balance at Jun. 30, 2022	1,952,012	$ 13	1,656,024	(7,553)	303,528	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		53,102
Exercise of stock option (in shares)		376,444
Exercise of stock options	2,044		2,044
Stock-based compensation	24,814		24,814
Other comprehensive income (loss)	(4,327)			(4,327)
Net (loss) income	175,312				175,312
Ending balance (in shares) at Sep. 30, 2022		133,027,358
Ending balance at Sep. 30, 2022	$ 2,149,855	$ 13	1,682,882	(11,880)	478,840	0
Beginning balance (in shares) at Dec. 31, 2022	133,236,687	133,236,687
Beginning balance at Dec. 31, 2022	$ 2,077,963	$ 13	1,709,835	(9,122)	377,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		690,811
Exercise of stock option (in shares)		455,485
Exercise of stock options	3,395		3,395
Issuance of common stock under employee stock purchase plan (in shares)		114,903
Issuance of common stock under employee stock purchase plan	2,605		2,605
Stock-based compensation	83,044		83,044
Contributions from noncontrolling interest owners	100					100
Other comprehensive income (loss)	7,222			7,222
Increase in ownership interest in a subsidiary	(100)		(56)			(44)
Net (loss) income	$ (499,144)				(499,088)	(56)
Ending balance (in shares) at Sep. 30, 2023	134,497,886	134,497,886
Ending balance at Sep. 30, 2023	$ 1,675,085	$ 13	1,798,823	(1,900)	(121,851)	0
Beginning balance (in shares) at Jun. 30, 2023		134,230,494
Beginning balance at Jun. 30, 2023	1,810,208	$ 13	1,771,536	(2,903)	41,562	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		73,351
Exercise of stock option (in shares)		194,041
Exercise of stock options	343		343
Stock-based compensation	26,944		26,944
Other comprehensive income (loss)	1,003			1,003
Net (loss) income	$ (163,413)				(163,413)
Ending balance (in shares) at Sep. 30, 2023	134,497,886	134,497,886
Ending balance at Sep. 30, 2023	$ 1,675,085	$ 13	$ 1,798,823	$ (1,900)	$ (121,851)	$ 0